nct02637284 bpc-157 status results BPC 157 for erectile dysfunction Stable Gastric Pentadecapeptide BPC 157

This is especially important for chronic pain patients who might use these peptides for a longer time

Current Access Options for BPC-157 While BPC-157 transitions through the regulatory process, patients may have several options depending on their location and healthcare provider: 503A compounding pharmacies: Some state-licensed pharmacies may still compound BPC-157 depending on their state's regulations and interpretation of the current federal guidance

This is particularly relevant for injectable formulations obtained outside standard pharmaceutical channels, where risks of contamination, endotoxin exposure, or improper compounding may exceed any theoretical biologic effect

For patients who cannot access the injury site with a self-injection, abdominal injection with the understanding that response may be somewhat slower is a practical alternative